Full Text View
Tabular View
No Study Results Posted
Related Studies
Gabapentin in Fibromyalgia Trial (GIFT)
This study has been completed.
Study NCT00057278   Information provided by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

First Received on March 28, 2003.   Last Updated on December 14, 2007   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Fibromyalgia
Additional conditions recognized in this trial
Myofascial Pain Syndromes
More general conditions related to this trial
Muscular Diseases
Musculoskeletal Diseases
Nervous System Diseases
Neuromuscular Diseases
Rheumatic Diseases
Interventions listed in this trial
gabapentin
More general drug interventions related to this trial
Analgesics
Anti-Anxiety Agents
Anti-Dyskinesia Agents
Anticonvulsants
Antimanic Agents
Antiparkinson Agents
Calcium Channel Blockers
Cardiovascular Agents
Central Nervous System Agents
Central Nervous System Depressants
Excitatory Amino Acid Agents
Excitatory Amino Acid Antagonists
Membrane Transport Modulators
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Sensory System Agents
Therapeutic Uses
Tranquilizing Agents
Sponsors listed in this trial
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services